Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Giant Lymph Node Hyperplasia
- Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas
- Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
- Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
- Tocilizumab for KSHV-Associated Multicentric Castleman Disease
- A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease
- A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment
- A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease
- Dose-escalation Study of Oral CX-4945
- A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease
- Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
- Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
- Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease